3 months DAPT

DRUG2 trials

Sponsors

Ajou University School of Medicine, Shanghai MicroPort Medical (Group) Co., Ltd.

Conditions

Drug-Eluting StentsPercutaneous Coronary InterventionStable Angina, Unstable Angina, Silent Coronary Ischemia, Coronary Artery Disease

Phase 4

ISAR-DAPT (A Comparative Evaluation of Efficacy and Safety in the 3-Months DAPT Group vs. the 6-Months DAPT Group of Patients Treated With the Coroflex ISAR Stent; A Prospective, Multicenter, Randomized, Open-Label Clinical Trial)

Ajou University School of MedicineStable Angina, Unstable Angina, Silent Coronary Ischemia, Coronary Artery Disease

Start: 2015-08-31End: 2019-06-30Target: 906Updated: 2015-11-20

Comparison Three vs Twelve Months of Dual Anti-Platelet Therapy After Stent Implantation

Shanghai MicroPort Medical (Group) Co., Ltd.Drug-Eluting Stents, Percutaneous Coronary Intervention

Start: 2019-01-10End: 2022-10-31Target: 2446Updated: 2020-09-09

Related Papers

Three vs 12-month DAPT after implantation of biodegradable-polymer sirolimus-eluting coronary stent: a randomised clinical trial.

2025-12-24

Prospective multicentre open-label randomised controlled trial of 3-month versus 12-month dual antiplatelet therapy after implantation of the new generation biodegradable polymer sirolimus TARGET-eluting coronary stent: protocol of the TARGET DAPT trial

BMJ Open2019-12-012 citations